In this regard, Cao et al. reported a significant reduction in tumor burden, and decreased phosphorylation levels of PI3K and Akt in the orthotopic mouse model of PDAC with NVP-BEZ235 dual-class I PI3K/mTOR inhibitor [45]. Here, AKT1 is linked to neoplasm.